Alterity Therapeutics Ltd (ASX:ATH)
A$ 0.005 0 (0%) Market Cap: 26.19 Mil Enterprise Value: 10.63 Mil PE Ratio: 0 PB Ratio: 0.56 GF Score: 0/100

Alterity Therapeutics Ltd MST Access Rare Diseases, Rich Returns Forum Transcript

Jun 29, 2023 / NTS GMT
Release Date Price: A$0.006 (-14.29%)
Rosemary Cummins
MST Access - Moderator

-- Inform Dr. Stamler. Just remind everyone that if you have any questions, please type them into the taskbar, of course, I'll be very happy to ask them at the end of each session. With that, I'd now like to introduce Dr. David Stamler from Alterity Therapeutics. Over to you, David.

David Stamler
Alterity Therapeutics Limited - CEO

Great. Thank you, Rosemary. I'm going to bring my presentation to share. And after I do that, maybe, Rosemary, you can tell me if you can see it in full-screen mode or --

Rosemary Cummins
MST Access - Moderator

It's full screen. No, it's not in -- you are not in full screen. Now you're at, you are fine.

David Stamler
Alterity Therapeutics Limited - CEO

It's full screen now. Okay, great.

Rosemary Cummins
MST Access - Moderator

Perfect.

David Stamler
Alterity Therapeutics Limited - CEO

All right, great. Well

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot